Industry News

Texas Tech University is renovating an 80,000-sf facility in Lubbock to create the Maddox Engineering Center. The $30 million project will provide classrooms, wet labs, and materials testing suites for the Edward E. Whitacre College of Engineering. A 25,000-sf materials characterization center, located in the basement, will be available for use by industry and academic partners. The project includes the complete renovation of a former mass communications building and the installation of new utilities, infrastructure, and finishes.

Our Lady of the Lake Medical Center broke ground in February of 2016 on a $230 million children's hospital in Baton Rouge. Providing advanced pediatric care and research facilities, the six-story, 350,000-sf project will include an emergency department, laboratories, surgical suites, inpatient rooms, and a dedicated hematology and oncology unit. An adjacent four-story, 95,000-sf medical office building will offer clinical space for pediatric medical specialties. Completion is expected in late 2018.
 

Novartis and the University of Pennsylvania Perelman School of Medicine celebrated the opening of the $27 million Center for Advanced Cellular Therapeutics in February of 2016 in Philadelphia. Accommodating the production of personalized cancer treatments using chimeric antigen receptor technology, the 30,000-sf facility features 23,610 sf of laboratory and cell therapy manufacturing space as well as a 6,300-sf cleanroom.

Bluffton University is planning to build the $14.5 million Austin E. Knowlton Science Center in Bluffton, Ohio. Housing the division of Natural and Applied Sciences, the 32,500-sf facility will provide three classrooms and 10 sustainably designed learning labs for programs in biology, chemistry, and dietetics. The center will support a progressive pedagogy with maximum internal transparency, enabling lab activities to be visible to students, staff, and visitors. Completion is expected in fall 2019.

Alnylam Pharmaceuticals broke ground in April of 2016 on a $200 million manufacturing plant in Norton, Mass. Featuring RNA synthesis technologies with advanced purification methods, the 200,000-sf facility will accommodate up to 220 workers engaged in the production of innovative therapeutic agents. Jacobs Engineering Group will provide engineering and procurement services for the project. Completion is expected in 2018.